Professor of Medicine, Washington University St Louis
Nephrology
Dr. James A. Delmez, MD
|
|
Give Review
James A. Delmez, MD works in the field of Nephrology. He researched medicine at University of Rochester School of Medicine and Dentistry. He received awards:"America's Top Doctors" and "St. Louis Magazine: Top Doctors". James Delmez is also a published MD. He has 85 publication published. The most recent publication is: Effects of carbohydrate restriction on the hypoglycemic phase of the glucose tolerance test. James A. Delmez, MD accepts all Medicare patients.
Publications
- Differential expression and regulation of Klotho by paricalcitol in the Kidney, parathyroid, and aorta of uremic rats.
- Cardiac and Renal Effects of Atrasentan in Combination With Enalapril and Paricalcitol in Uremic Rats.
- A randomized, double-blind, placebo-controlled trial of niacinamide for reduction of Phosphorus in hemodialysis patients.
- Relationship between volume status and blood pressure during Chronic hemodialysis.
- Effects of carbohydrate restriction on the hypoglycemic phase of the glucose tolerance test.
- Diverticular disease in patients with chronic renal failure due to polycystic Kidney disease.
- Physiologic mechanisms of action of lovastatin in Nephrotic syndrome.
- Alternative phosphate binders in dialysis patients: Calcium carbonate.
- Dialysis dose and the effect of gender and body size on outcome in the HEMO Study.
- A randomized, parallel, open-label study to compare once-daily sevelamer carbonate powder dosing With thrice-daily sevelamer hydrochloride tablet dosing in CKD patient...
- Association of achieved dialysis dose With mortality in the hemodialysis study: an example of "dose-targeting bias".
- Association between serum 2-microglobulin level and infectious mortality in hemodialysis patients.
- Relation of serum fetuin-A levels to coronary artery Calcium in African-American patients on chronic hemodialysis.
- Association of Acidosis and nutritional parameters in hemodialysis patients.
- A randomized, double-blind, crossover design study of sevelamer hydrochloride and sevelamer carbonate in patients on hemodialysis.
- Alteration of mineral metabolism in chronic renal Failure.
- Renal osteodystrophy: past and future.
- Calcium carbonate as a phosphate binder in patients with chronic renal Failure undergoing dialysis.
- Cardiovascular and metabolic Responses to submaximal exercise in hemodialysis patients.
- Kinetics of monocyte 1 alpha-hydroxylase in renal Failure.
- Suppression of Parathyroid hormone secretion in hemodialysis patients by a novel vitamin D analogue: 19-nor-1,25-dihydroxyvitamin D2.
- Impaired delivery of hemodialysis prescriptions: an analysis of causes and an approach to evaluation.
- ExtraRenal production of calcitriol in normal and uremic humans.
- Effects of calcitriol and non-calcemic vitamin D analogs on secondary hyperParathyroidism.
- ExtraRenal production of calcitriol.
- The parathyroid-calcitriol axis in health and chronic renal Failure.
- Long-term effects of Calcium carbonate and 2.5 mEq/liter Calcium dialysate on mineral metabolism.
- Accelerated removal of deferoxamine mesylate-chelated aluminum by charcoal hemoperfusion in hemodialysis patients.
- Pathogenesis of secondary hyperParathyroidism.
- The metabolic and psychological effects of exercise training in hemodialysis patients.
- Metabolic effects of exercise training in hemodialysis patients.
- Peripheral nerve entrapment syndromes in Chronic hemodialysis patients.
- [Effects of prazosin on the control of arterial pressure in Hypertensive patients subjected to dialysis].
- Minerals, vitamin D, and parathyroid hormone in continuous ambulatory peritoneal dialysis.
- Psychological effects of exercise training in hemodialysis patients.
- Studies on the role of the liver and splanchnic tissues in the production of carbohydrate intolerance in uremia.
- Host immunity and spontaneous regression of cancer evaluated by computerized data reduction study.
- Some biochemical changes preceding regression of 7,12-dimethylbenz(a)anthracene-induced mammary tumors following oophorectomy.
- Exercise training reduces coronary risk and effectively rehabilitates hemodialysis patients.
- Does strict phosphorus control precipitate Renal osteomalacia?
- Continuous ambulatory peritoneal dialysis and bone.
- The effects of intraperitoneal calcitriol on Calcium and parathyroid hormone.
- Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to Calcium.
- Control of mineral Metabolism in CAPD patients.
- Severe dialyzer dysfunction undetectable by standard reprocessing validation tests.
- Optimization of high-efficiency hemodialysis by detection and correction of fistula dysfunction.
- The short-term effects of a low-protein diet in stable Renal transplant recipients.
- Clinical review 20: Recent advances in the pathogenesis and therapy of uremic secondary hyperParathyroidism.
- Calcium acetate as a phosphorus binder in hemodialysis patients.
- Prosthetic fistula survival and complications in hemodialysis patients: effects of Diabetes and age.
- Hyperphosphatemia: its consequences and treatment in patients with Chronic renal disease.
- Hemodialysis prescription and delivery in a metropolitan community. The St. Louis Nephrology Study Group.
- Effects of exercise training on coronary risk factors in hemodialysis patients.
- Exercise training improves abnormal lipid and carbohydrate Metabolism in hemodialysis patients.
- Prevention of thrombosis in patients on hemodialysis by low-dose aspirin.
- Effects of prazosin in the control of blood pressure in Hypertensive dialysis patients.
- Bone Disease in long-term dialysis.
- Comparison of survival of an expanded polytetrafluoroethylene graft designed for early cannulation to standard wall polytetrafluoroethylene grafts.
- Magnesium carbonate as a Phosphorus binder: a prospective, controlled, crossover study.
- Impaired delivery of dialysis: diagnosis and correction.
- The spectrum of Renal osteodystrophy in peritoneal dialysis patients.
- Calcitriol and secondary hyperParathyroidism in continuous ambulatory peritoneal dialysis patients.
- Removal of Phosphorus by peritoneal dialysis.
- Factors affecting delivery of high-efficiency dialysis using temporary vascular access.
- Long-term complications of dialysis: pathogenetic factors With special reference to bone.
- Cardiac troponin I. A marker With high specificity for cardiac injury.
- The successful treatment of recurrent nephrotic syndrome with the MOPP regimen in a patient with a remote history of Hodgkin's Disease.
- Acute effects of different concentrations of dialysate magnesium during high-efficiency dialysis.
- Modulation of Renal osteodystrophy by extraRenal production of calcitriol.
- Progress report: The AJKD matures.
- A controlled trial of the early treatment of secondary hyperparathyroidism With calcitriol in hemodialysis patients.
- Factors associated With the prevalence of arteriovenous fistulas in hemodialysis patients in the HEMO study. Hemodialysis (HEMO) Study Group.
- Insulin-like growth factor 1 enhances renal function in a patient with chronic renal Failure on peritoneal dialysis.
- Uremia reduces serum insulin-like growth factor I, increases insulin-like growth factor II, and modifies their serum protein binding.
- Exercise training improves Hypertension in hemodialysis patients.
- Therapeutic benefits of exercise training for hemodialysis patients.
- Use of aspirin associates With longer primary patency of hemodialysis grafts.
- Effects of sodium thiosulfate on vascular calcification in end-stage renal Disease: a pilot study of feasibility, safety and efficacy.
- The effect of oral niacinamide on plasma Phosphorus levels in peritoneal dialysis patients.
- Effect of dipyridamole plus aspirin on hemodialysis graft patency.
- Efficacy and safety of a new kappa-opioid receptor agonist for the treatment of uremic pruritus.
- Cerebrovascular Disease in maintenance hemodialysis patients: results of the HEMO Study.
- Effect of dialysis dose and membrane flux in maintenance hemodialysis.
- Effect of clopidogrel on early Failure of arteriovenous fistulas for hemodialysis: a randomized controlled trial.
Schools
University Of Rochester School Of Medicine and Dentistry
Barnes Jewish Hospital
Procedures Preformed
- Hemodialysis
- Peritoneal Dialysis
Conditions Treated
- Acidosis
- Acute Kidney Failure
- Calcium Metabolism Disorders
- Chronic Glomerulonephritis
- View All
Doctors Specialties
- Nephrology
Accepted Insurances
Awards
- America's Top Doctors
- St. Louis Magazine: Top Doctors
Education
-
Washington University - Barnes-Jewish Hospital -
University of Rochester School of Medicine and Dentistry
Hospital
-
Barnes-Jewish Hospital
Drug Facts
| NPI NUMBER | 1306862537 | |
| NPPES Provider LastName | DELMEZ | |
| NPPES Provider FirstName | JAMES | |
| NPPES Provider ZIPCode | 631101032 | |
| NPPES Provider State | MO | |
| Specialty Description | Nephrology | |
| Total Claim Count | 1492.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1306862537 |
| Last Name Of The Provider | DELMEZ |
| First Name Of The Provider | JAMES |
| View All |
Similar Doctors
|
|
Dr. Alexandra I. Voinescu, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Nazia Kulsum-Mecci, MB BS |
|
|
Dr. Syed M. Rizvi, MD |
|
|
Dr. Steven C. Cheng, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bhajan S. Dara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bhavani Adusumilli, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Decha Enkvetchakul, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Willie R. Ross, MD |
|
|
Dr. Erik D. Daniels, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sangeeta Pande, MD |
|
|
Dr. Karthikapallil Antony, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lissa M. Lopez-Rocafort, MD |
|
|
Dr. Kamalanthan K. Sambandam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Esther A. Gonzalez, MD |